Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q104129536 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241221010634.0 | ||
| 008 | 241221nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q104129536 | ||
| 024 | ‡a 0000-0002-0958-6242 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q104129536 | ||
| 100 | 0 | ‡a Marcus Vinícius Magno Gonçalves ‡c researcher ‡9 en | |
| 400 | 0 | ‡a Marcus Vinícius Magno Gonçalves ‡c onderzoeker ‡9 nl | |
| 670 | ‡a Author's Alternatives for reducing relapse rate when switching from natalizumab to fingolimod in multiple sclerosis | ||
| 670 | ‡a Author's Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis | ||
| 670 | ‡a Author's Cerebrum-cervical arterial dissection in adults during sports and recreation. | ||
| 670 | ‡a Author's Correlation between IL-31 and sCD40L plasma levels in Fingolimod-treated patients with Relapsing-Remitting Multiple Sclerosis (RRMS) | ||
| 670 | ‡a Author's High levels of alexithymia in patients with multiple sclerosis. | ||
| 670 | ‡a Author's MOG-IgG-associated disorder and systemic lupus erythematosus disease: Systematic review | ||
| 670 | ‡a Author's Patients' satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis | ||
| 670 | ‡a Author's Persistent headache in patients with multiple sclerosis starting treatment with fingolimod. | ||
| 670 | ‡a Author's Postpartum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother | ||
| 670 | ‡a Author's Real-life experience with fampridine (Fampyra®) for patients with multiple sclerosis and gait disorders | ||
| 670 | ‡a Author's Serological profile of John Cunningham virus | ||
| 670 | ‡a Author's Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis | ||
| 670 | ‡a Author's Superficial siderosis of the central nervous system is a rare and possibly underdiagnosed disorder | ||
| 670 | ‡a Author's Unfavorable outcomes during treatment of multiple sclerosis with high doses of vitamin D | ||
| 909 | ‡a (orcid) 0000000209586242 ‡9 1 | ||
| 919 | ‡a unfavorableoutcomesduringtreatmentofmultiplesclerosiswithhighdosesofvitamin500 ‡A Unfavorable outcomes during treatment of multiple sclerosis with high doses of vitamin D ‡9 1 | ||
| 919 | ‡a superficialsiderosisofthecentralnervoussystemisarareandpossiblyunderdiagnoseddisorder ‡A Superficial siderosis of the central nervous system is a rare and possibly underdiagnosed disorder ‡9 1 | ||
| 919 | ‡a serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis ‡A Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis ‡9 1 | ||
| 919 | ‡a serologicalprofileofjohncunninghamvirus ‡A Serological profile of John Cunningham virus ‡9 1 | ||
| 919 | ‡a reallifeexperiencewithfampridinefampyraforpatientswithmultiplesclerosisandgaitdisorders ‡A Real-life experience with fampridine (Fampyra®) for patients with multiple sclerosis and gait disorders ‡9 1 | ||
| 919 | ‡a postpartumtreatmentwithimmunoglobulindoesnotpreventrelapsesofmultiplesclerosisinthemother ‡A Postpartum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother ‡9 1 | ||
| 919 | ‡a persistentheadacheinpatientswithmultiplesclerosisstartingtreatmentwithfingolimod ‡A Persistent headache in patients with multiple sclerosis starting treatment with fingolimod. ‡9 1 | ||
| 919 | ‡a patientssatisfactionwithandviewsabouttreatmentwithdiseasemodifyingdrugsinmultiplesclerosis ‡A Patients' satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis ‡9 1 | ||
| 919 | ‡a mogiggassociateddisorderandsystemiclupuserythematosusdiseasesystematicreview ‡A MOG-IgG-associated disorder and systemic lupus erythematosus disease: Systematic review ‡9 1 | ||
| 919 | ‡a highlevelsofalexithymiainpatientswithmultiplesclerosis ‡A High levels of alexithymia in patients with multiple sclerosis. ‡9 1 | ||
| 919 | ‡a correlationbetweenil31andscd40lplasmalevelsinfingolimodtreatedpatientswithrelapsingremittingmultiplesclerosisrrms ‡A Correlation between IL-31 and sCD40L plasma levels in Fingolimod-treated patients with Relapsing-Remitting Multiple Sclerosis (RRMS) ‡9 1 | ||
| 919 | ‡a cerebrumcervicalarterialdissectioninadultsduringsportsandrecreation ‡A Cerebrum-cervical arterial dissection in adults during sports and recreation. ‡9 1 | ||
| 919 | ‡a brazilianconsensusforthetreatmentofmultiplesclerosisbrazilianacademyofneurologyandbraziliancommitteeontreatmentandresearchinmultiplesclerosis ‡A Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis ‡9 1 | ||
| 919 | ‡a alternativesforreducingrelapseratewhenswitchingfromnatalizumabtofingolimodinmultiplesclerosis ‡A Alternatives for reducing relapse rate when switching from natalizumab to fingolimod in multiple sclerosis ‡9 1 | ||
| 996 | ‡2 ISNI|0000000067649868 | ||
| 996 | ‡2 ISNI|0000000044093780 | ||
| 996 | ‡2 ISNI|0000000113891242 | ||
| 996 | ‡2 NTA|316175331 | ||
| 996 | ‡2 BLBNB|000402499 | ||
| 996 | ‡2 SUDOC|145409651 | ||
| 996 | ‡2 BLBNB|000985182 | ||
| 996 | ‡2 LC|n 2011213434 | ||
| 996 | ‡2 LC|n 96099712 | ||
| 996 | ‡2 PTBNP|1237423 | ||
| 996 | ‡2 SUDOC|25379756X | ||
| 996 | ‡2 LC|n 2006013704 | ||
| 996 | ‡2 ISNI|000000005221372X | ||
| 996 | ‡2 ISNI|0000000067812768 | ||
| 996 | ‡2 BLBNB|001118662 | ||
| 996 | ‡2 LC|n 93017804 | ||
| 996 | ‡2 J9U|987007328246905171 | ||
| 996 | ‡2 PTBNP|1846794 | ||
| 996 | ‡2 ISNI|0000000040240325 | ||
| 996 | ‡2 BLBNB|000582186 | ||
| 996 | ‡2 BLBNB|000219670 | ||
| 996 | ‡2 BNF|15016650 | ||
| 996 | ‡2 BLBNB|001570425 | ||
| 996 | ‡2 LC|no2005030600 | ||
| 996 | ‡2 BLBNB|000207263 | ||
| 996 | ‡2 BIBSYS|97013476 | ||
| 996 | ‡2 SUDOC|154460206 | ||
| 996 | ‡2 DNB|1056290986 | ||
| 996 | ‡2 BIBSYS|97029247 | ||
| 996 | ‡2 LC|no2006125235 | ||
| 996 | ‡2 BLBNB|000459774 | ||
| 996 | ‡2 DNB|144021730 | ||
| 996 | ‡2 BLBNB|000371006 | ||
| 996 | ‡2 BIBSYS|14051401 | ||
| 996 | ‡2 BLBNB|000231725 | ||
| 996 | ‡2 BNF|16064413 | ||
| 996 | ‡2 LC|no2004025407 | ||
| 996 | ‡2 BNF|16728462 | ||
| 996 | ‡2 SUDOC|121680592 | ||
| 996 | ‡2 PTBNP|1784767 | ||
| 996 | ‡2 RERO|A026961003 | ||
| 996 | ‡2 BLBNB|000396749 | ||
| 996 | ‡2 PTBNP|247186 | ||
| 996 | ‡2 CAOONL|ncf10716608 | ||
| 996 | ‡2 BLBNB|000536278 | ||
| 996 | ‡2 PTBNP|1584600 | ||
| 996 | ‡2 ISNI|0000000033022864 | ||
| 996 | ‡2 DNB|1264567588 | ||
| 996 | ‡2 PTBNP|1432417 | ||
| 996 | ‡2 BLBNB|000430217 | ||
| 996 | ‡2 CAOONL|ncf12112647 | ||
| 996 | ‡2 BLBNB|000578853 | ||
| 996 | ‡2 ISNI|0000000035038122 | ||
| 996 | ‡2 ISNI|0000000057043264 | ||
| 996 | ‡2 LC|n 96121873 | ||
| 996 | ‡2 DNB|1057276537 | ||
| 996 | ‡2 SUDOC|270068503 | ||
| 996 | ‡2 NDL|00801600 | ||
| 996 | ‡2 DNB|1349663484 | ||
| 996 | ‡2 PTBNP|102029 | ||
| 996 | ‡2 BLBNB|000258169 | ||
| 996 | ‡2 PTBNP|1417958 | ||
| 996 | ‡2 ISNI|0000000097833164 | ||
| 996 | ‡2 ISNI|0000000139552687 | ||
| 996 | ‡2 LC|n 86871226 | ||
| 996 | ‡2 BLBNB|000400173 | ||
| 996 | ‡2 PLWABN|9810563263205606 | ||
| 996 | ‡2 BLBNB|000341873 | ||
| 996 | ‡2 LC|n 2008215927 | ||
| 996 | ‡2 LC|no2003066006 | ||
| 996 | ‡2 NUKAT|n 2021212820 | ||
| 996 | ‡2 RERO|A006117195 | ||
| 996 | ‡2 J9U|987007328409205171 | ||
| 996 | ‡2 SUDOC|165341807 | ||
| 996 | ‡2 ISNI|000000005351302X | ||
| 996 | ‡2 NSK|000270416 | ||
| 996 | ‡2 RERO|A005919427 | ||
| 996 | ‡2 PTBNP|1558307 | ||
| 996 | ‡2 BLBNB|000219681 | ||
| 996 | ‡2 ISNI|0000000069888686 | ||
| 996 | ‡2 ISNI|0000000053920872 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
